In 40 seconds
Ankylosing spondylitis (AS) — now part of the broader axial spondyloarthritis (axSpA) classification — affects approximately 200,000 UK adults, with strong association with HLA-B27 genetic marker. Symptoms: chronic inflammatory back pain (worse with rest, better with movement), spinal stiffness, sometimes peripheral arthritis, uveitis, IBD. UK care follows NICE NG65: NSAIDs first-line, biologics (anti-TNF, anti-IL-17A) for active disease, regular exercise (particularly hydrotherapy), specialist physiotherapy. PEMF therapy is a non-pharmacological adjunct for inflammation and mobility — alongside, never instead of, biologic therapy.
Quick facts
- UK prevalence: ≈ 200,000 adults
- HLA-B27 association: ≈ 90% of patients positive
- Standard care: NSAIDs + biologics + exercise per NICE NG65
- PEMF role: Inflammation, mobility, sleep, pain
- Sessions: 30 min, 2× per week for 8-12 weeks
- Foundation: Rheumatology specialist + biologics + exercise
AS needs disease-modifying treatment
Ankylosing spondylitis is a chronic inflammatory arthritis primarily affecting the axial skeleton (spine and sacroiliac joints), with strong genetic association (HLA-B27). Without treatment, AS can progressively limit spinal mobility and produce structural change ("bamboo spine" on imaging in advanced cases).
UK care has been transformed by biologic therapy:
- NSAIDs — first-line; some specialists use continuously, others on-demand
- Biologics — anti-TNF (adalimumab, etanercept, infliximab, golimumab, certolizumab), anti-IL-17A (secukinumab, ixekizumab), JAK inhibitors. Transformative for active AS not responding to NSAIDs.
- Exercise — particularly hydrotherapy and structured exercise programmes; one of the strongest non-pharmacological interventions
- Specialist physiotherapy — extension and rotation work to maintain mobility
- Surgery — for advanced complications
PEMF therapy is not a replacement for biologics. AS without disease-modifying treatment progresses; biologics changed outcomes. PEMF is a supportive adjunct.
How PEMF may help AS
- Inflammation reduction — supports the broader anti-inflammatory effort alongside biologics
- Mobility maintenance — pain reduction enables better engagement with exercise
- Sacroiliac inflammation — early AS often presents with SI joint inflammation
- Sleep architecture — pain-disrupted sleep is itself pain-amplifying
- Comorbid pain conditions — fibromyalgia and tendinopathies common
- Fatigue — chronic inflammation drives fatigue; PEMF supports recovery
Typical UK protocol
| Phase | Frequency | Focus |
|---|---|---|
| Trial | 2× per week × 3 weeks | BASDAI baseline, tolerability |
| Loading | 2× per week × 8 weeks | Pain, mobility, sleep gains |
| Maintenance | 1× per fortnight | Sustain function alongside biologics |
Track BASDAI (Bath Ankylosing Spondylitis Disease Activity Index), BASMI (mobility), and patient-reported function. PEMF effects show on symptoms; biologics change disease activity.
Practical advice
- Get rheumatology specialist care — AS needs disease-modifying treatment, not just symptomatic adjuncts
- Stay on biologics — these prevent progression. Don't stop without rheumatologist input
- Exercise is foundational — daily exercise (particularly hydrotherapy and extension work) is among the strongest evidence-based interventions
- Address comorbidities — uveitis (urgent ophthalmology), IBD, fatigue, mood
- PEMF as one piece — supports inflammation and mobility alongside everything else
Related guides on PEMF UK
PEMF for rheumatoid arthritis
Different inflammatory arthritis, similar approach.
SymptomPEMF for lower back pain
Inflammatory back pain is core AS feature.
MechanismPEMF for SI joints
SI inflammation is hallmark of axSpA (in horses too).
Contraindications
Hard exclusions — do not have PEMF if any apply:
- Pacemaker, implantable cardioverter-defibrillator (ICD), or any cardiac electronic device
- Cochlear implant or other implanted electronic hearing device
- Spinal cord stimulator, deep-brain stimulator, vagus nerve stimulator
- Intrathecal pump or implanted drug pump
- Insulin pump (continuous glucose monitors are usually fine — confirm with the clinic)
- Active infection at the treatment site
- Pregnancy — when treatment would be over the abdomen, lumbar spine, or pelvis
Discuss with your GP or specialist before booking if any apply:
- Active malignancy or recent cancer history (oncologist clearance required)
- History of seizures or epilepsy
- Multiple sclerosis or other neurological condition under specialist care
- Anticoagulant therapy (PEMF itself does not thin blood, but bruising risk if local circulation is already compromised)
- Children under 14 (most UK clinics will not treat under-18s without paediatric specialist input)
- Recent surgery within the last 14 days at the treatment site (confirm with surgeon)
NOT contraindications — these are commonly misunderstood:
- Plates, rods, screws and other passive metal orthopaedic hardware
- Dental implants and dental crowns
- Joint replacements (hip, knee, shoulder)
- IUDs (copper or hormonal)
- Tattoos and piercings (jewellery should be removed for the session)
Specific to this condition: Don't stop biologic therapy. AS without disease-modifying treatment progresses to structural change. Don't stop NSAIDs without rheumatologist input. PEMF is symptomatic adjunct only.
Frequently asked questions
Will PEMF replace my biologic?
No. Biologics (anti-TNF, anti-IL-17A) are disease-modifying — they slow progression. PEMF is symptomatic only. Never stop biologics without rheumatologist input.
Will PEMF help my morning stiffness?
Possibly — morning stiffness is partly inflammatory. PEMF's anti-inflammatory effects may help alongside NSAIDs and biologics.
Can I have PEMF if I have a fused spine?
Yes — passive structural change isn't a contraindication. PEMF supports remaining mobile segments and surrounding soft tissue.
Will it interact with adalimumab / secukinumab / other biologics?
No documented interactions. PEMF and biologics target different mechanisms; combination is safe.
Should I do hydrotherapy AND PEMF?
Yes — both have evidence in AS. Hydrotherapy for mobility, PEMF for inflammation and pain. Many UK patients combine.
Cost?
Typical UK clinic £40-£90 per session. 8-week course £640-£1,440. Compare against the value of biologic therapy (free on NHS for eligible patients) and NHS hydrotherapy access.
Find a PEMF clinic near you
We list every credible PEMF therapy provider in the UK so you can find one near home.